| DIRECT COMPETITOR COMPARISON | |
| IDXX | LLY | HSKA | WOOF | Industry | | Market Cap: | 2.98B | 42.81B | 21.89M | 1.99B | 61.07M | | Employees: | 4,700 | 40,500 | 312 | 9,000 | 56 | | Qtrly Rev Growth (yoy): | 3.20% | 6.80% | -9.80% | 2.00% | 21.40% | | Revenue (ttm): | 1.00B | 21.11B | 73.75M | 1.30B | 12.73M | | Gross Margin (ttm): | 51.15% | 82.33% | 35.48% | 27.84% | 50.63% | | EBITDA (ttm): | 216.89M | 7.74B | 4.16M | 288.36M | -1.76M | | Oper Margins (ttm): | 16.69% | 30.97% | 1.71% | 19.29% | -19.80% | | Net Income (ttm): | 114.83M | -216.00M | -85.00K | 131.77M | N/A | | EPS (ttm): | 1.888 | -0.197 | -0.002 | 1.536 | -0.10 | | P/E (ttm): | 26.90 | N/A | N/A | 15.19 | 23.50 | | PEG (5 yr expected): | 1.43 | 4.04 | N/A | 1.07 | 1.37 | | P/S (ttm): | 2.95 | 2.03 | 0.28 | 1.53 | 3.31 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.28 | 0.85% | 57.98B | 12.49 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.38 | 0.00% | 13.70B | 15.86 | | Genzyme Corp. | GENZ | 51.01 | 1.25% | 13.54B | 29.08 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.88 | -0.17% | 42.19B | 18.13 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.80 | 1.24% | 9.06B | 1036.73 | | Teva Pharmaceutical Industries Limited | TEVA | 53.06 | -0.39% | 46.75B | 48.55 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.76 | 1.92% | 4.01B | 19.46 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.07 | -0.08% | 3.00B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.33 | 0.16% | 5.60B | 112.45 | | Pfizer Inc. | PFE | 18.47 | 0.87% | 149.04B | 15.34 | | Johnson & Johnson | JNJ | 63.26 | 0.13% | 174.54B | 13.82 | | GlaxoSmithKline plc | GSK | 42.83 | 1.30% | 108.57B | 13.47 | | Sanofi-Aventis | SNY | 39.42 | 2.05% | 102.93B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.74 | 0.80% | 126.60B | 16.69 | | RHHBY.PK | 42.05 | 1.45% | N/A | N/A | | AstraZeneca plc | AZN | 46.36 | 2.45% | 67.22B | 9.31 | | Abbott Laboratories | ABT | 54.4425 | 0.37% | 84.21B | 14.75 | | Bristol-Myers Squibb Co. | BMY | 25.52 | 1.43% | 50.55B | 13.20 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | LLY | | Forgetful patients lift support consultancies
Tue 6:05pm -
at FT.com | | • | LLY | | [video] Topping the Tape
Tue 5:20pm -
at CNBC | | • | LLY | | Seven Dividend Stocks to Take the Emotion Out of Investing
Tue 1:59pm -
at Seeking Alpha | | • | WOOF | | VCA Antech, Inc. to Speak at the 21st Piper Jaffray Health Care Conference 2009
Mon, Nov 23 -
GlobeNewswire | | • | LLY | | Good News for Bristol-Myers
Mon, Nov 23 -
Zacks.com | | • | LLY | | [$$] Sanofi Has Lots of Upside Catalysts
Mon, Nov 23 -
at RealMoney by TheStreet.com | | • | LLY | | Worse Than You Think
Fri, Nov 20 -
at Forbes.com | | • | LLY | | Big Pharma Mergers: Good News Or Bad?
Fri, Nov 20 -
Investor's Business Daily | | • | HSKA | | Heska Announces Launch of New Website
Thu, Nov 19 -
PR Newswire | | • | WOOF | | sound-eklin Announces Exclusive Partnership With GE Healthcare to Meet Veterinary Ultrasound Needs
Mon, Nov 16 -
Marketwire | | • | HSKA | | HESKA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Thu, Nov 12 -
EDGAR Online | | • | WOOF | | VCA Antech, Inc. to Speak at the Sodoti Emerging Growth Institutional Investor Conference II
Thu, Nov 12 -
GlobeNewswire | | • | WOOF | | VCA ANTECH INC Financials
Wed, Nov 11 -
EDGAR Online Financials | | • | WOOF | | VCA ANTECH INC Files SEC form 10-Q, Quarterly Report
Fri, Nov 6 -
EDGAR Online | | • | HSKA | | HESKA CORP Financials
Tue, Nov 3 -
EDGAR Online Financials | | • | HSKA | | HESKA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Tue, Oct 27 -
EDGAR Online | | • | HSKA | | Heska Announces Q309 Results
Tue, Oct 27 -
PR Newswire | | | All Headlines for these symbols... |
|
|
|
0.19% Nasdaq 
Competitors
